CTN
0.003
50%
CRS
0.098
-21.6%
CHM
0.004
33.3%
BAP
1.87
-20.4%
FCT
0.009
28.6%
CKA
0.057
-16.2%
CMO
0.019
26.7%
EWC
0.039
-15.2%
IMM
0.322
26.3%
AX8
0.006
-14.3%
AVE
0.01
25%
HWK
0.025
-13.8%
OD6
0.1
25%
DUB
0.014
-12.5%
WR1
0.387
24.8%
NOR
0.014
-12.5%
ALY
0.011
22.2%
OCT
0.043
-12.2%
MAY
0.011
22.2%
TER
0.097
-11.8%
AUA
0.035
20.7%
ARV
0.008
-11.1%
LSR
0.018
20%
ATH
0.008
-11.1%
DTZ
0.053
17.8%
NGX
0.125
-10.7%
TSL
0.007
16.7%
SVG
0.017
-10.5%
IAM
0.034
13.3%
N1H
0.13
-10.3%
TSK
0.135
12.5%
HE8
0.009
-10%
LML
0.01
11.1%
RAD
0.019
-9.5%
EDU
0.88
10.7%
DTR
0.222
-9.4%
CCR
0.26
10.6%
ANX
0.01
-9.1%
LDX
0.27
10.2%
IMI
0.01
-9.1%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

AVITA Medical (ASX:AVH) signed an exclusive 5 year distribution agreement with Stedical Scientific

AVITA Medical (ASX:AVH) signed an exclusive five year distribution agreement with Stedical Scientific, to commercialise PermeaDerm® Biosynthetic Wound Matrix in the U.S. The matrix is cleared by the U.S. FDA and used for a variety of injuries | https://announcements.asx.com.au/asxpdf/20240111/pdf/05zbp446ftpyw0.pdf #FDA #PermeaDerm #AVH